QPWM
BIIB icon

Quadrant Private Wealth Management’s Biogen BIIB Stock Holding History

Quadrant Private Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-901
Closed -$256K – 187
2020
Q3 		$256K Sell
901
-7
-0.8% -$1.95K 0.13% 149
2020
Q2 		$243K Buy
908
+277
+44% +$83.3K 0.14% 150
2020
Q1 		$200K Buy
+631
New +$191K 0.17% 132

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quadrant Private Wealth Management's BIIB Position: Q4 2020 in Review

Quadrant Private Wealth Management sold out of Biogen (BIIB) in Q4 2020, closing a stake of 901 shares — an estimated $256K sold.

Quadrant Private Wealth Management first reported a position in BIIB in Q1 2020 and held it in 3 quarters. The position peaked at $256K in Q3 2020. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Quadrant Private Wealth Management reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • Quadrant Private Wealth Management sold 901 Biogen shares in Q4 2020, an estimated $256K.
  • Quadrant Private Wealth Management first reported a position in Biogen in Q1 2020 and held it in 3 quarters.
  • Quadrant Private Wealth Management's Biogen position peaked at $256K in Q3 2020.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Quadrant Private Wealth Management's 13F filing for Q4 2020, filed 12 Feb 2021.